Self-Administered Mepolizumab in the Management of Severe Asthma: Usability and Patient Acceptance
Reika Miyokawa,1 Celeste Kivler,1 Samuel Louie,1 Dorottya Godor,2 Laren Tan,3 Nicholas Kenyon1,4 1Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, University of California Davis, Sacramento, CA 95817, USA; 2Northwick Park Hospital London North West University...
Main Authors: | Miyokawa R, Kivler C, Louie S, Godor D, Tan L, Kenyon N |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-09-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/self-administered-mepolizumab-in-the-management-of-severe-asthma-usabi-peer-reviewed-article-PPA |
Similar Items
-
Clinical usefulness of mepolizumab in severe eosinophilic asthma
by: Menzella F, et al.
Published: (2016-06-01) -
Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma
by: Terufumi Shimoda, et al.
Published: (2017-07-01) -
Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
by: Haldar P
Published: (2017-06-01) -
Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
by: Steven W. Yancey, et al.
Published: (2019-09-01) -
Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab
by: Carpagnano GE, et al.
Published: (2019-03-01)